- Joined
- Aug 4, 2020
- Messages
- 1,967
- Reaction score
- 3,354
The magic of non-purposeful RT dose to the axilla?
The cosmetic outcome with PBI compared to WBI favors PBI in every trial using a regimen that is NOT 38.5 in 10 fractions BID.
40/15 PBI and 30/5 PBI both have less acute AND late toxicity than WBI regimens they were compared to.
26/5 PBI we have no prospective data for but presumably would cause less toxicity than 26/5 WBI.
Your internal justification to avoid learning how to do PBI is wrong. If you're gonna act like a boomer RO and ignore new techniques/data that would benefit patients, then go ahead and just own it. Lord knows there are enough ROs nationwide who feel similarly.
Yeah, so if you want to #fractionshame #volumeshame by all means, you do that.
My 55+ yo patients have done great with hypofrac whole breast no boost, and particularly for those who are ER+, and may not tolerate endocrine therapy, I see no need to change.
I'd appreciate it if you wouldn't assume I'm a boomer, or for that matter, feel this discussion warrants a personal attack.
If we can misgrade GU toxicity in prostate, I'm sure we can do the same for breast (see post elsewhere). "Are you happy with your treatment" is the bottom line, and nearly all women who get hypofrac whole breast are pleased.